FLASCO’s strength is the involvement of its member volunteers who provide their time, effort and expertise to further the operations and initiatives of the Society. Currently, FLASCO maintains eight standing committees.
The Bylaws Committee is responsible for considering and making recommendations to the Board of Directors on changes in Bylaws and Articles of Incorporation. View FLASCO Bylaws here.
Clinical Practice Committee
The Clinical Practice Committee is responsible for compiling, monitoring and maintaining a library of oncology clinical practice parameters. The committee will act as a liaison with other agencies that deal with practice parameters and will serve as a resource to the membership.
The Disparities Committee was established in 2019. The goal of this committee is to narrow the disparity in cancer patients in Florida in-line with the Healthy People 2030 national program. The committee focuses their work on five key areas: Awareness, Advocacy, Access, Research, and Education.
The Ethics Committee is responsible for assisting physicians, patients and families in making medical care decisions that are of ethical, legal and humane nature. The committee may act upon matters that have occurred in the past or present or may occur in the future. Discussion in this committee may remain private or openly discussed depending upon the subject material and the parties involved. The nature of the subjects are diverse covering practical decisions to problems concerning physician, patients and family members, third party payors, pharmaceutical industry and health affiliated entrepreneurial adventures or activities as examples.
The Finance Committee is responsible for: (1) reviewing and making recommendations to the Executive Committee in November of each year regarding proposed committee initiatives for the following year; (2) reviewing the annual budget developed by the FLASCO Executive Director; and, after consideration of such items shall present a budget to the Executive Committee for approval in December of each year; (3) reviewing semi-annually the Society’s investments and report the results of such performance along with any recommended changes to the board of Directors; and (4) reviewing all financial documents received from the FLASCO accountant each month. The Finance Committee shall consist of the President, Vice President, Treasurer and a Chairman.
The Legislative Committee is responsible for identifying and considering public policy issues related to cancer care and clinical research; identifying areas for potential advocacy intervention, considering advocacy strategies to meet policy objectives; providing general oversight of activities; identifying unaddressed needs; reviewing and approving draft policy documents prior to submission to the Board; advocating within established FLASCO public policy on issues related to cancer care and clinical research; identifying and assigning priority to issues requiring potential advocacy intervention; and establishing a grassroots advocacy network.
The Membership Committee is responsible for recommending membership requirements and policies and for making appropriate recommendations to the Executive Committee or Board of Directors on each new applicant.
A Nominating Committee of no less than (5) members shall be appointed each year by the President with the consent and approval of the Executive Committee or the Board of Directors approximately six (6) months prior to the annual meeting. The responsibilities of this committee will be to nominate Officers and members of the Board of Directors and of the Executive Committee. Nominations may come from the floor.
The Program Committee is responsible for developing and arranging the scientific programs held in conjunction with the Society’s meetings with the advice and consent of the Board of Directors or the Executive Committee.
As payment models transition to quality models of revenue, the FLASCO Quality Committee works to share best practices with FLASCO members and create educational content focusing on Quality.
FLASCO has a variety of working groups that collaborate to develop strategies, guidelines, and initiatives aimed to improve cancer care, enhance patient outcomes, and promote awareness about cancer-related issues at the state level.
The APP Consortium
The APP Consortium is an ad hoc committee open to all Florida APP FLASCO members. Volunteers from the APP Consortium, in a whole, will come together to discuss best practices and disseminate educational, and complete projects. The consortium will utilize the focus groups to logistically solve challenges, develop processes, and actively work in related task forces.
FLASCO believes that Advanced Practice Providers (APP) including, Physician Assistants (PA) and Advanced Practice Registered Nurses (APRN) have advanced clinical knowledge and skills designed to provide direct and indirect care for oncology patients. FLASCO endorses the integration of APPs in our care delivery model.
The Pharmacy Consortium
The Pharmacy Consortium is to encompass all the current FLASCO efforts surrounding Pharmacy and to potentiate and develop new avenues for collaborations among PharmD and other FLASCO members/groups. Education, Membership, Advocacy/Outreach, & Research will be the four main areas of focus.
Pharmacy Student Taskforce
The mission of FLASCO Pharmacy Student Working Group is to bring together inter-professional healthcare students dedicated to serve cancer patients and the community. We will provide access to expert oncologist, oncology pharmacists, and nurses with high standard of care to guide students interested in oncology.
The RN Consortium
The RN Consortium was created to identify the unique needs of Florida Oncology RNs. The RN Consortium is developing a state-wide network of Oncology RNs and a virtual networking resource to facilitate open discussion about the specific challenges encountered as an Oncology RN. FLASCO is dedicated to investing in educational opportunities, networking, and supportive resources for Florida’s oncology RNs.
The mission of the FLASCO Administrator Network is to enhance communications among practice administrators and other leaders of oncology within community oncology practices, hospital based practices and academic practices, especially relating to operational and reimbursement issues.
Pediatric Oncology Consortium
The goal of the Pediatric Oncology Consortium is to establish a strong network of pediatric oncology professionals to communicate and collaborate on furthering cancer research, education, advocacy, and empowerment in all aspects of pediatric oncology.
The Neuro-Oncology Consortium was developed to bring together thought leaders to further the understanding and awareness of brain metastases, and drive research and innovation towards advancements in neuro-oncology treatments and therapies.